A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This randomised, double-blind, placebo-controlled study will evaluate the efficacy and safety
of ADC3680 administered once daily as an add-on therapy to inhaled corticosteroids and when
co-administered with montelukast in patients with inadequately-controlled asthma. Patients
will be randomised to 3 Arms to receive ADC3680, placebo or montelukast.